Pharmaceutical composition for oral Administration for the treatment of irritable bowel syndrome on the basis of a modifier of intestinal motility.An agent that prevents the retention of Gas and Digestive Enzyme and Process for S
BERNARDO ESCUDERO, ROBERTO,SAVOIR VILBOUEF, JOHN CLAUDE
申请号：
CR20130219
公开号：
CR20130219A
申请日:
2013.05.14
申请国别(地区):
CR
年份:
2013
代理人:
摘要：
The invention relates to a pharmaceutical formulation or composition intended to be administered orally in the form of a tablet, a coated tablet or a capsule, for the prevention or treatment of intestinal disorders, such as irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, digestive enzymes, a binding agent, a diluent, an adsorbent agent, a disintegrating agent, a lubricant and a glidant, effective for normalising colon transit, for providing an analgesic activity, for providing an antispasmodic activity and for reducing symptoms related to intestinal gas, such as distention, abdominal pain and flatulence.
